NDC 47781-381
Pregabalin Extended Release
Pregabalin
Pregabalin Extended Release is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Alvogen Inc.. The primary component is Pregabalin.
| Product ID | 47781-381_7bb60ea1-b02e-e3a3-f2e2-d5a78f25c978 |
| NDC | 47781-381 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pregabalin Extended Release |
| Generic Name | Pregabalin |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-04-14 |
| Marketing Category | ANDA / |
| Application Number | ANDA211593 |
| Labeler Name | Alvogen Inc. |
| Substance Name | PREGABALIN |
| Active Ingredient Strength | 330 mg/1 |
| DEA Schedule | CV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |